Novel strategy for manufacturing autologous dendritic cell / allogeneic tumor lysate vaccines for glioblastoma

curncman
Posts: 1017
Joined: Fri Jun 26, 2020 8:27 am

Immunologic aspects of dendritic cell-derived EVs for cancer therapy by Susanne Gabrielsson

Post by curncman »

Immunologic aspects of dendritic cell-derived EVs for cancer therapy by Susanne Gabrielsson

curncman
Posts: 1017
Joined: Fri Jun 26, 2020 8:27 am

NEURON - PART 2 - AXON AND DENDRITES

Post by curncman »

NEURON - PART 2 - AXON AND DENDRITES

curncman
Posts: 1017
Joined: Fri Jun 26, 2020 8:27 am

Manipulating "Cross-dressing" Immune Cells to Prevent Transplant Rejection

Post by curncman »

Manipulating "Cross-dressing" Immune Cells to Prevent Transplant Rejection

User avatar
TimGDixon
Posts: 1189
Joined: Fri Jun 26, 2020 4:36 am

Re: Novel strategy for manufacturing autologous dendritic cell / allogeneic tumor lysate vaccines for glioblastoma

Post by TimGDixon »

Interesting paper. Thanks for posting.
curncman wrote: Fri Aug 28, 2020 12:53 am Novel strategy for manufacturing autologous dendritic cell / allogeneic tumor lysate vaccines for glioblastoma'

https://academic.oup.com/noa/advance-ar ... 05/5897132

Abstract
Background
Glioblastoma, the most common primary malignant brain tumor, is nearly universally fatal by five years. Dendritic cell vaccines are promising but often limited clinically by antigen choice, dendritic cell potency, and/or manufacturing yield. We optimized vaccine manufacture, generating potent mature autologous dendritic cells pulsed with allogeneic glioblastoma lysates.
curncman
Posts: 1017
Joined: Fri Jun 26, 2020 8:27 am

Hands-On Workshop: iPSC Derived Cell Types for Perturbation Biology | LINCS Virtual Symposium 2020

Post by curncman »

Hands-On Workshop: iPSC Derived Cell Types for Perturbation Biology | LINCS Virtual Symposium 2020


Panel: Next Generation Approaches Using iPSCs





Your Funds at Work! Fall 2020 Grants Webinar

Post Reply